Aspirin Prevention of Colorectal Cancer: Focus on NF-κB Signalling and the Nucleolus

Jingyu Chen, Lesley A Stark

Research output: Contribution to journalReview articlepeer-review

Abstract / Description of output

Overwhelming evidence indicates that aspirin and related non-steroidal anti-inflammatory drugs (NSAIDs) have anti-tumour activity and the potential to prevent cancer, particularly colorectal cancer. However, the mechanisms underlying this effect remain hypothetical. Dysregulation of the nuclear factor-kappaB (NF-κB) transcription factor is a common event in many cancer types which contributes to tumour initiation and progression by driving expression of pro-proliferative/anti-apoptotic genes. In this review, we will focus on the current knowledge regarding NSAID effects on the NF-κB signalling pathway in pre-cancerous and cancerous lesions, and the evidence that these effects contribute to the anti-tumour activity of the agents. The nuclear organelle, the nucleolus, is emerging as a central regulator of transcription factor activity and cell growth and death. Nucleolar function is dysregulated in the majority of cancers which promotes cancer growth through direct and indirect mechanisms. Hence, this organelle is emerging as a promising target for novel therapeutic agents. Here, we will also discuss evidence for crosstalk between the NF-κB pathway and nucleoli, the role that this cross-talk has in the anti-tumour effects of NSAIDs and ways forward to exploit this crosstalk for therapeutic purpose.

Original languageEnglish
Issue number3
Publication statusPublished - 18 Jul 2017

Keywords / Materials (for Non-textual outputs)

  • Journal Article
  • Review


Dive into the research topics of 'Aspirin Prevention of Colorectal Cancer: Focus on NF-κB Signalling and the Nucleolus'. Together they form a unique fingerprint.

Cite this